Efficacy, safety, and pharmacokinetics of subcutaneous azacitidine in Taiwanese patients with higher-risk myelodysplastic syndromes-Reference-Cited by-同舟云学术

Efficacy, safety, and pharmacokinetics of subcutaneous azacitidine in Taiwanese patients with higher-risk myelodysplastic syndromes

Published:2017-01-25 Issue:5 Volume:13 Page:e430-e439
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clin Oncol

Author:

Chou Wen-Chien¹,Yeh Su-Peng²,Hsiao Liang-Tsai³,Lin Sheng-Fung⁴,Chen Yeu-Chin⁵,Chen Tsai-Yun⁶,Laille Eric⁷,Galettis Anoula⁷,Dong Qian⁷,Songer Steve⁷,Beach CL⁷

Affiliation:

1. National Taiwan University Hospital; Taipei Taiwan

2. China Medical University Hospital; Taichung City Taiwan

3. Taipei Veterans General Hospital and National Yang-Ming University School of Medicine; Taipei Taiwan

4. Kaohsiung Medical University Hospital and Kaohsiung Medical University; School of Medicine; Kaohsiung Taiwan

5. Tri-Service General Hospital; National Defense Medical Center; Taipei City Taiwan

6. National Cheng-Kung University Hospital; Tainan Taiwan

7. Celgene Corporation; Summit; New Jersey USA

Funder

Celgene

Publisher

Wiley

Subject

Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12659/fullpdf

Reference38 articles.

1. Reactivating the expression of methylation silenced genes in human cancer;Karpf;Oncogene,2002

2. Cancer epigenetics comes of age;Jones;Nat Genet,1999

3. Hypermethylation of the p15INK4B gene in myelodysplastic syndromes;Uchida;Blood,1997

4. Toxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation;Juttermann;Proc Natl Acad Sci USA,1994

5. 5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy;Christman;Oncogene,2002

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse Event Profile of Azacitidine: Analysis by Route of Administration Using Japanese Pharmacovigilance Database;Oncology;2023

2. Historical expectations with DNA methyltransferase inhibitor monotherapy in MDS: when is combination therapy truly “promising”?;Blood Advances;2022-05-05

3. Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends;Journal of Biomedical Science;2021-04-12

4. Epigenetic Research in Stem Cell Bioengineering—Anti-Cancer Therapy, Regenerative and Reconstructive Medicine in Human Clinical Trials;Cancers;2020-04-21